Targeting multidrug resistance in cancer - Test2 - elhamkhani - TriplyDB

Targeting multidrug resistance in cancer

Targeting multidrug resistance in cancer

http://www.wikidata.org/entity/Q29616803

about

Continuous quinacrine treatment results in the formation of drug-resistant prions Cellular robustness conferred by genetic crosstalk underlies resistance against chemotherapeutic drug doxorubicin in fission yeast Anticancer effects of the nitric oxide-modified saquinavir derivative saquinavir-NO against multidrug-resistant cancer cells Involvement of ABC transporters in melanogenesis and the development of multidrug resistance of melanoma Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding Mechanisms of drug resistance in colon cancer and its therapeutic strategies Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells Phytochemicals and Biogenic Metallic Nanoparticles as Anticancer Agents Emerging Role of miRNAs in the Drug Resistance of Gastric Cancer Molecular Mechanisms and Potential Clinical Applications of Campylobacter jejuni Cytolethal Distending Toxin Role of microRNAs in chemoresistance Caveolin-1, a stress-related oncotarget, in drug resistance Multiple cues on the physiochemical, mesenchymal, and intracellular trafficking interactions with nanocarriers to maximize tumor target efficiency Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology Ten things you should know about protein kinases: IUPHAR Review 14 Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approach Chemoresistance and Cancer-Related Inflammation: Two Hallmarks of Cancer Connected by an Atypical Link, PKCζ Physiology and pathophysiology of the blood-brain barrier: P-glycoprotein and occludin trafficking as therapeutic targets to optimize central nervous system drug delivery Polymers influencing transportability profile of drug Nanocarrier-mediated co-delivery of chemotherapeutic drugs and gene agents for cancer treatment Overcoming drug resistance in multi-drug resistant cancers and microorganisms: a conceptual framework The pharmacological impact of ATP-binding cassette drug transporters on vemurafenib-based therapy The clinically relevant pharmacogenomic changes in acute myelogenous leukemia Biophysics of cell membrane lipids in cancer drug resistance: Implications for drug transport and drug delivery with nanoparticles Peptidomimetics as a new generation of antimicrobial agents: current progress Marine natural products as breast cancer resistance protein inhibitors Overcoming multidrug resistance via photodestruction of ABCG2-rich extracellular vesicles sequestering photosensitive chemotherapeutics Regulation of Multi-drug Resistance in hepatocellular carcinoma cells is TRPC6/Calcium Dependent.Structure and function of ABCG2-rich extracellular vesicles mediating multidrug resistance Structural basis for gating mechanisms of a eukaryotic P-glycoprotein homolog.Advances in the molecular detection of ABC transporters involved in multidrug resistance in cancer Biomolecular Network-Based Synergistic Drug Combination Discovery EMT, CTCs and CSCs in tumor relapse and drug-resistance ABCB6 is dispensable for erythropoiesis and specifies the new blood group system Langereis The PIM kinases in hematological cancers Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers Chemophototherapy: An Emerging Treatment Option for Solid Tumors Anticancer efficacy of a nitric oxide-modified derivative of bifendate against multidrug-resistant cancer cells

P2860

Q21090510-C40147D8-5620-48B6-8D45-DD7013F6357B Q21133734-4C6E4173-7673-49FC-AF45-38B59D926A3C Q24628715-21C1D2FE-D7B0-45EF-86B0-E8E3F7BFF943 Q24649754-71AEF511-9A64-43EE-A901-7C986217F2F6 Q24657908-2CB6EFF0-F533-451E-8EE0-CAC973A30DCC Q26738528-675046DE-4434-4A11-B173-151F7D1D84B9 Q26748850-3B47A62B-8DD1-45C3-AC56-03F2FDD29140 Q26750806-04275DE8-224A-4A01-857F-6C2749592DF9 Q26752006-B349F385-E2BB-46A2-91E5-8436A71A82A5 Q26767241-9D42E094-983F-41A4-952F-5457B1D47C0D Q26770485-2AC2564E-CAF5-4DBC-AB49-3947C45F90F2 Q26782615-AA763886-C3F5-41C9-9482-10D8C0C111F1 Q26827999-A09A0777-F833-42BD-BB4D-33F14C186447 Q26828930-34DEE649-50E5-4E9B-B1F0-1CFAFB0B9BF4 Q26830028-F0D1E4AD-C955-429E-BA9E-FD5793C9F945 Q26849264-E716C0CB-847A-420C-B297-08497729E18C Q26849417-1BF6E518-0D24-4122-BA5E-BDCDDC4559B3 Q26849477-5B65C8DB-0743-4160-BF7A-61FB54C058E9 Q26853683-0086D0B3-8E5F-407D-ACA2-26DA62DF75CD Q26861408-231A5C3F-0780-46A3-8F57-AC369DA24129 Q26862824-C2CBED52-1FD6-4F44-952C-8376AAFCA53C Q26866566-7D81EB3E-03E3-4C04-9338-211CE35114A1 Q27000458-4E4E6996-559B-4A47-969F-42F15CE91530 Q27004672-E7AF1B79-59D8-477E-8FDF-1519875FB009 Q27014790-C16BE11E-5C46-4DDF-80D1-EE6C7117450B Q27026080-1307EA5D-C800-4874-AF2E-1AD32E093F0F Q27026959-353A033C-630C-4ED9-A3E5-BED94A52BECA Q27027706-021D40DC-3584-4815-91BE-D71761678909 Q27304425-A8A9BC04-40AA-4A57-AAF5-A13D541F4404 Q27330365-B2458111-946A-4F22-9F2F-FDE4F25A82CB Q27437985-0E1C0085-B02C-438A-AB35-F96639F6DA8F Q27681970-8C65F00A-8326-48E7-A3D3-509225280047 Q27694658-69677767-A182-4C5F-AC53-E3EDDC26A5B9 Q28077880-D9A66316-CD18-4C8B-BE1D-FB362320527D Q28082935-EE906240-4897-4DAE-9FDA-C6B4ED37109A Q28257493-13C96F22-2538-43FA-8EB7-67BA51189533 Q28258028-5607B7D5-EE84-4AFC-A998-8668DFD53798 Q28282826-8C44547E-D8E3-4F4F-BE51-43F262B176F2 Q28468315-B2A497BB-53F9-4A47-8BBE-488AC2349C40 Q28468523-756262BC-C16E-4BB3-A2BD-64C30E38F4D9

P2860

Targeting multidrug resistance in cancer

http://www.wikidata.org/entity/Q29616803

description

2006 nî lūn-bûn

@nan

2006 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մարտին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Targeting multidrug resistance in cancer

@ast

Targeting multidrug resistance in cancer

@en

type

label

Targeting multidrug resistance in cancer

@ast

Targeting multidrug resistance in cancer

@en

prefLabel

Targeting multidrug resistance in cancer

@ast

Targeting multidrug resistance in cancer

@en

P1433

Q29616803-A757F597-9F28-4E83-ADCC-FD99DC0C72DF

P1476

Q29616803-BF85131E-B6A1-497D-A04B-7631CC03FE65

P2093

Q29616803-24DA3CE4-26E8-4DB0-B7A0-DB5A10A639BE

Q29616803-368A0000-1829-4194-8396-41EFF14EAF97

Q29616803-A6ED8580-D424-491A-88C7-7C2A269033F5

Q29616803-C4CFA156-F882-4F0D-97B9-BF4B09CDC8ED

Q29616803-C4E2934B-AD32-41E6-AF85-262AF1C525A6

P2860

Q29616803-01CA8735-E975-4317-9350-BD15E94325C1

Q29616803-033A5A70-2938-4DD9-93EC-E1CF3D546771

Q29616803-06023FC9-5EB1-4B1A-BC0C-DE60CDA7AF92

Q29616803-082ED9AA-0FEA-4E2C-AC7E-D6A5FE0A1FAE

Q29616803-09075437-7635-449E-8FDA-51ED6FDA3C16

Q29616803-0940A0A6-E7AA-4AA3-8870-81D75EAEE234

Q29616803-09C27ACE-37CC-4DDA-8F0C-3878CE5C596A

Q29616803-0A094CC2-6520-4740-A7D6-C8AA80E74BA6

Q29616803-0D5726E5-4C4D-46CF-A119-4CAE7169CBB7

Q29616803-0F76DEBF-8485-49AA-A67A-E44313CA3FD6

P2888

Q29616803-D4D2A87D-7BEC-4D2F-9A17-960E5D6D1A61

P304

Q29616803-E1A55C55-ABDA-4296-A75D-7DE6A453E13E

P31

Q29616803-68ADF2F2-353A-438D-819D-6FA6BC4B5737

P3181

Q29616803-45F00E2A-CCA7-435B-811F-E556EC28F43B

P356

Q29616803-24C59F2A-F768-4B09-84A6-DFE210A581F7

P407

Q29616803-81253F21-5752-4A01-9BD9-583A45D3BDF3

P433

Q29616803-7E32166E-0C03-4B9F-B0F7-C797825300A5

P478

Q29616803-71B19AAB-0E2C-4971-8D76-D23C29DA6270

P577

Q29616803-31BEC535-2430-4D0B-B47C-1E896074FC24

P5875

Q29616803-4337FFA6-683C-479B-9FBA-740D46D2D7F2

P6179

Q29616803-CB4E52B0-C177-4987-AB18-E2BA60C53599

P698

Q29616803-65616814-507B-4880-B7BA-F02EADF69C80

P921

Q29616803-9E644C54-75B8-4A2D-BE4E-6FA9AD7E6A37

P3181

P356

P1433

Nature Reviews Drug Discovery

P1476

Targeting multidrug resistance in cancer

@en

P2093

Booth-Genthe C

http://www.w3.org/2001/XMLSchema#string

Gottesman MM

http://www.w3.org/2001/XMLSchema#string

Ludwig JA

http://www.w3.org/2001/XMLSchema#string

Paterson JK

http://www.w3.org/2001/XMLSchema#string

Szakács G

http://www.w3.org/2001/XMLSchema#string

P2860

A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis

A multidrug resistance transporter from human MCF-7 breast cancer cells

MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2',3'-dideoxycytidine and 9'-(2'-phosphonylmethoxyethyl)adenine

Transport of bile acids, sulfated steroids, estradiol 17-beta-D-glucuronide, and leukotriene C4 by human multidrug resistance protein 8 (ABCC11)

MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine

Phosphatidylcholine translocase: a physiological role for the mdr2 gene

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

MRP3, an organic anion transporter able to transport anti-cancer drugs

Multidrug resistance related molecules in human and murine lung

P2888

P304

219-34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

400221

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NRD1984

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2006-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7260477

http://www.w3.org/2001/XMLSchema#string

P6179

1042314065

http://www.w3.org/2001/XMLSchema#string

P698

16518375

http://www.w3.org/2001/XMLSchema#string

P921

multiple drug resistance